DLC1: A Key Tumor Suppressor in Rho GTPase Signaling

Comprehensive genomic and functional analysis of DLC1 (Deleted in Liver Cancer 1)

Gene Information Card

Symbol DLC1
Full Name Deleted in Liver Cancer 1
Gene Type Protein coding
Chromosomal Location 8p22
NCBI Gene ID 10395 ncbi.nlm.nih.gov/gene/10395
Ensembl ID ENSG00000164741
UniProt ID Q96QB1
OMIM ID 604259
HGNC ID 2895
Aliases ARHGAP7, STARD12, p122-RhoGAP

Description

DLC1 (Deleted in Liver Cancer 1) encodes a Rho GTPase-activating protein (RhoGAP) that negatively regulates RhoA, Rac1, and Cdc42 signaling. It functions as a tumor suppressor frequently inactivated by deletion or promoter hypermethylation in hepatocellular carcinoma and other cancers. DLC1 also contains a sterile alpha motif (SAM) domain and a START lipid-binding domain, contributing to its role in cell adhesion, migration, and proliferation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hepatocellular carcinoma Loss of DLC1 expression via deletion or methylation leads to RhoA activation and increased cell motility Frequent deletion at 8p22 in HCC; re-expression suppresses tumor growth (PMID: 10700184)
Breast cancer DLC1 downregulation correlates with poor prognosis; re-expression inhibits invasion Reduced DLC1 mRNA in breast tumors (PMID: 15604238)
Lung cancer Promoter hypermethylation silences DLC1 in non-small cell lung cancer Methylation detected in 40% of NSCLC (PMID: 15604238)
Prostate cancer DLC1 loss associated with metastatic progression Deletion and reduced expression in prostate cancer cell lines (PMID: 15604238)

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 8.5 Medium
Lung 6.2 Low
Breast 4.1 Low
Prostate 3.8 Low
Brain 2.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 12.3 Hepatocellular carcinoma cell line
A549 5.7 Lung adenocarcinoma cell line
MCF7 3.2 Breast cancer cell line
PC3 2.1 Prostate cancer cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense Rare Loss of start codon; likely loss of function
c.124C>T (p.Arg42*) Nonsense Rare Premature stop; loss of function
c.1453G>A (p.Glu485Lys) Missense Rare Unknown; predicted damaging
Deletion of 8p22 Copy number loss Common in HCC Loss of heterozygosity; reduced DLC1 expression
Mutation functional classification

Loss of Function (LOF)

Most DLC1 mutations are loss-of-function, including nonsense, frameshift, and deletions that impair RhoGAP activity or protein stability.

Gain of Function (GOF)

No gain-of-function mutations reported; DLC1 is a tumor suppressor.

Dominant Negative (DN)

No dominant-negative mutations described; loss of one allele via deletion is common.

Pathways

• Rho GTPase cycle (R-HSA-194840)
• Signaling by Rho GTPases (R-HSA-194315)
• RhoA signaling pathway (WP198)

Protein Summary

DLC1 is a 1091-amino acid protein containing an N-terminal SAM domain, a central RhoGAP domain, and a C-terminal START domain. The RhoGAP domain catalyzes GTP hydrolysis on RhoA, Rac1, and Cdc42, thereby inactivating these small GTPases. DLC1 localizes to focal adhesions and regulates actin cytoskeleton dynamics, cell migration, and proliferation. Loss of DLC1 function promotes oncogenic transformation and metastasis.

Related Products

Product name Cat.No. Species Gene ID
DLC1 Knockout HEK293 Cell Line EDJ-KQ3908 Human 10395 Details Get a Quote
DLC1 Knockout A-549 Cell Line EDJ-KQ26128 Human 10395 Details Get a Quote
DLC1 Knockout HeLa Cell Line EDJ-KQ55399 Human 10395 Details Get a Quote
DLC1 Knockout HCT 116 Cell Line EDJ-KQ72337 Human 10395 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: